secwatch.observer — SEC 8-K summary
======================================

Issuer:     VOLITIONRX LTD (VNRX)
CIK:        0000093314
Form:       8-K
Filed at:   2025-03-26T23:59:59+00:00
Accession:  0001477932-25-002010
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VolitionRx announces $2.3M registered direct offering; insiders buy 2.36M shares at $0.55
--------------------------------------------------------------------------------

- 2,363,636 shares sold to insiders (directors, officers, existing stockholders) at $0.55/share.
- 1,739,087 shares + warrants (exercise $0.66, 5-year) sold to other investors at $0.55 combined.
- Gross proceeds $2.3M upfront; up to $1.1M additional if warrants fully exercised.
- Net proceeds for R&D, clinical studies, product commercialization, and working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/93314/000147793225002010/0001477932-25-002010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/93314/000147793225002010/vnrx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-25-002010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer